|
Originally published In Press as doi:10.1074/jbc.M102610200 on May 1, 2001
J. Biol. Chem., Vol. 276, Issue 27, 24806-24816, July 6, 2001
Transactivation Specificity of Glucocorticoid Versus
Progesterone Receptors
ROLE OF FUNCTIONALLY DIFFERENT INTERACTIONS OF TRANSCRIPTION
FACTORS WITH AMINO- AND CARBOXYL-TERMINAL RECEPTOR DOMAINS*
Liang-Nian
Song ,
Barbara
Huse§,
Sandro
Rusconi§, and
S. Stoney
Simons Jr. ¶
From the Steroid Hormones Section, NIDDK/LMCB,
National Institutes of Health, Bethesda, Maryland 20892 and
§ Université de Fribourg Suisse, CH-1700
Fribourg, Switzerland
A major unanswered question of glucocorticoid and
progesterone action is how different whole cell responses arise when
both of the cognate receptors can bind to, and activate, the same
hormone response elements. We have documented previously that the
EC50 of agonist complexes, and the partial agonist
activity of antagonist complexes, of both glucocorticoid receptors
(GRs) and progesterone receptors (PRs) are modulated by increased
amounts of homologous receptor and of coregulators. We now ask whether
these components can differentially alter GR and PR transcriptional
properties. To remove possible cell-specific differences, we have
examined both receptors in the common environment of a line of mouse
mammary adenocarcinoma (1470.2) cells. In order to segregate the
responses that might be due to unequal nucleosome reorganization by the two receptors from those reflecting interactions with other components, we chose a transiently transfected reporter containing a simple glucocorticoid response element (i.e. GREtkLUC). No
significant differences are found with elevated levels of either
receptor. However, major, qualitative differences are seen with the
corepressors SMRT and NCoR, which afford opposite responses with GR and
PR. Studies with chimeric GR/PR receptors indicate that no one segment of PR or GR is responsible for these properties and that the composite response likely involves interactions with both the amino and carboxyl
termini of receptors. Collectively, the data suggest that GR and PR
induction of responsive genes in a given cell can be differentially
controlled, in part, by unequal interactions of multiple receptor
domains with assorted nuclear cofactors.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Bldg. 8, Rm.
B2A-07, NIDDK/LMCB, National Institutes of Health, Bethesda, MD 20892. Tel.: 301-496-6796; Fax: 301-402-3572.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L.-N. Song and E. P. Gelmann
Silencing Mediator for Retinoid and Thyroid Hormone Receptor and Nuclear Receptor Corepressor Attenuate Transcriptional Activation by the {beta}-Catenin-TCF4 Complex
J. Biol. Chem.,
September 19, 2008;
283(38):
25988 - 25999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. He and S. S. Simons Jr.
STAMP, a Novel Predicted Factor Assisting TIF2 Actions in Glucocorticoid Receptor-Mediated Induction and Repression
Mol. Cell. Biol.,
February 15, 2007;
27(4):
1467 - 1485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Georgiakaki, N. Chabbert-Buffet, B. Dasen, G. Meduri, S. Wenk, L. Rajhi, L. Amazit, A. Chauchereau, C. W. Burger, L. J. Blok, et al.
Ligand-Controlled Interaction of Histone Acetyltransferase Binding to ORC-1 (HBO1) with the N-Terminal Transactivating Domain of Progesterone Receptor Induces Steroid Receptor Coactivator 1-Dependent Coactivation of Transcription
Mol. Endocrinol.,
September 1, 2006;
20(9):
2122 - 2140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Wang and S. S. Simons Jr.
Corepressor Binding to Progesterone and Glucocorticoid Receptors Involves the Activation Function-1 Domain and Is Inhibited by Molybdate
Mol. Endocrinol.,
June 1, 2005;
19(6):
1483 - 1500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Palmieri, D. O. Halverson, T. Ouatas, C. E. Horak, M. Salerno, J. Johnson, W. D. Figg, M. Hollingshead, S. Hursting, D. Berrigan, et al.
Medroxyprogesterone Acetate Elevation of Nm23-H1 Metastasis Suppressor Expression in Hormone Receptor-Negative Breast Cancer
J Natl Cancer Inst,
May 4, 2005;
97(9):
632 - 642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Cho, B. L. Kagan, J. A. Blackford Jr., D. Szapary, and S. S. Simons Jr.
Glucocorticoid Receptor Ligand Binding Domain Is Sufficient for the Modulation of Glucocorticoid Induction Properties by Homologous Receptors, Coactivator Transcription Intermediary Factor 2, and Ubc9
Mol. Endocrinol.,
February 1, 2005;
19(2):
290 - 311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Wang, J. A. Blackford Jr., L.-N. Song, Y. Huang, S. Cho, and S. S. Simons Jr.
Equilibrium Interactions of Corepressors and Coactivators with Agonist and Antagonist Complexes of Glucocorticoid Receptors
Mol. Endocrinol.,
June 1, 2004;
18(6):
1376 - 1395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. He, D. Szapary, and S. S. Simons Jr.
Modulation of Induction Properties of Glucocorticoid Receptor-Agonist and -Antagonist Complexes by Coactivators Involves Binding to Receptors but Is Independent of Ability of Coactivators to Augment Transactivation
J. Biol. Chem.,
December 13, 2002;
277(51):
49256 - 49266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kaul, P. J. M. Murphy, J. Chen, L. Brown, W. B. Pratt, and S. S. Simons Jr.
Mutations at Positions 547-553 of Rat Glucocorticoid Receptors Reveal That hsp90 Binding Requires the Presence, but Not Defined Composition, of a Seven-amino Acid Sequence at the Amino Terminus of the Ligand Binding Domain
J. Biol. Chem.,
September 20, 2002;
277(39):
36223 - 36232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schulz, M. Eggert, A. Baniahmad, A. Dostert, T. Heinzel, and R. Renkawitz
RU486-induced Glucocorticoid Receptor Agonism Is Controlled by the Receptor N Terminus and by Corepressor Binding
J. Biol. Chem.,
July 12, 2002;
277(29):
26238 - 26243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chen, S. Kaul, and S. S. Simons Jr.
Structure/Activity Elements of the Multifunctional Protein, GMEB-1. CHARACTERIZATION OF DOMAINS RELEVANT FOR THE MODULATION OF GLUCOCORTICOID RECEPTOR TRANSACTIVATION PROPERTIES
J. Biol. Chem.,
June 7, 2002;
277(24):
22053 - 22062.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kaul, J. A. Blackford Jr., S. Cho, and S. S. Simons Jr.
Ubc9 Is a Novel Modulator of the Induction Properties of Glucocorticoid Receptors
J. Biol. Chem.,
April 5, 2002;
277(15):
12541 - 12549.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|